Table 7.
Summary of Survey of Probe Utilization for Neoplastic Disorders in 1995*
| No. of Cases | bcr/abl | X and Y | Centromeric Probes | Whole Chromosome Libraries | PML/RARA |
|---|---|---|---|---|---|
| None | 105 | 133 | 114 | 123 | 152 |
| 1–10 | 68 | 55 | 61 | 77 | 52 |
| 11–30 | 27 | 8 | 24 | 10 | 4 |
| 31–50 | 5 | 5 | 9 | 2 | 3 |
| 51–100 | 4 | 5 | 1 | 2 | 2 |
| >100 | 7 | 8 | 6 | 1 | 1 |
| Total No. of laboratories | 216 | 214 | 215 | 215 | 214 |
| No. of FISH laboratories | 111 | 81 | 101 | 92 | 62 |
| No. of specimens studied | >1424 | >1353 | >1255 | >451 | >391 |
*
Data provided by American College of Medical Genetics/College of American Pathologists cytogenetics survey participants. FISH indicates fluorescence in situ hybridization.